2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the

27 Pages·2015·1.48 MB·English

by  Hindricks Gerhard

2015 ESC Guidelines for the
management of patients with
ventricular arrhythmias and
the prevention of sudden
cardiac death
The Task Force for the Management of
Patients with Ventricular Arrhythmias
and the Prevention of Sudden Cardiac
Death of the European Society of
Cardiology (ESC)
European Heart Journal 2015
doi/10.1093/eurheartj/ehv316
2
www.escardio.org
European Heart Journal 2015 doi/10.1093/eurheartj/ehv316
3
The 2015 ESC Guidelines for the management of
VA and prevention of SCD
• To describe and explain the epidemiology and pathophysiology of
ventricular arrhythmias and SCD
• To provide an up-to-date summary on current knowledge but also –
and even more important – of current knowledge gaps
• To come up with the best consensus on available and reasonable
diagnostics and therapies
• To provide practical and clinical help to identify patients at risk for
ventricular arrhythmia and sudden cardiac death.
• To guide the management of VA and SCD and thereby promoting
the best outcome to improve quality of life and reduce the burden of
SCD
• To raise further awareness on the global threat of SCD.
www.escardio.org
II
100
AOP
0
II
100
AOP
0
6
Autopsy and molecular autopsy in sudden death
victims
• ~ 50% of cardiac arrests occur in individuals without known heart
disease, but most suffer from concealed ischaemic heart disease.
• Every time a heritable disease is identified in a deceased individual,
the relatives may be at risk of being affected and dying suddenly.
www.escardio.org
Diagnostic workup in patients presenting with sustained
ventricular tachycardia or ventricular fibrillation
www.escardio.org
8
Diagnostic workup in patients presenting with sustained
ventricular tachycardia or ventricular fibrillation
www.escardio.org
Speaker
9
Diagnostic workup in patients presenting with sustained
ventricular tachycardia or ventricular fibrillation
www.escardio.org
Speaker
10
Therapies for ventricular arrhythmias
• Pharmacotherapy for VA and prevention of SCD
• With the exception of beta-blockers, currently
available AAD have not been shown in RCT to be
effective in primary management of patients with
life-threatening VA or in prevention of SCD.
• Each drug has a significant potential for causing
adverse events, including pro-arrhythmia.
www.escardio.org